Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

2.

In inflammatory breast cancer, ER beta regulates estrogen signaling.

3.

Preferred and Actual Location of Death Often Don't Match for Young Cancer Patients

4.

Traces of bacteria inside brain tumors may affect tumor behavior

5.

Smart exercise planning could boost recovery for people with cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot